ESCMID offers small innovative pharmaceutical companies with early-stage antimicrobial therapies in development a platform to present their products to a wider audience.

Join us for our antimicrobial drug pipeline talks at ECCMID 2016 in Amsterdam!

After successful initiation of the Pipeline Corner and the Pipeline Talks at ECCMID 2015 in Copenhagen, the ECCMID Programme Committee decided to further extend the new format at ECCMID 2016 in Amsterdam. ECCMID will provide a platform for small innovative companies to give an overview of their R&D pipelines and present recent advances in their early-stage programmes to a wider audience. Applications by small pharmaceutical companies from Europe and from outside Europe are accepted. 

The dedicated session will take place at ECCMID 2016 in Amsterdam

on Sunday, 10 April 2016, 13:00 - 14:00 at the Pipeline Corner.

Presenting companies:

  • BioVersys, Switzerland
  • Melinta, United States
  • Deutsches Zentrum für Infektionsforschung, Germany
  • Discuva, United Kingdom
  • Cidara, United States
  • Spero, United States
  • ABAC Therapeutics, Spain
  • Biovertis, Germany
  • Nabriva, Austria
  • Vitas Pharma, India

The pilot phase for the Pipeline Corner and the Pipeline Talks at ECCMID will be be extended through 2016. Therefore participants will only have regular congress registration costs an no additional costs.

For more information you may contact Ursula Theuretzbacher.